Unlocking the Potential of B4GALT7: A Potential Drug Target and Biomarker for Proteostasis

Target Name: B4GALT7

NCBI ID: G11285

B4GALT7

Unlocking the Potential of B4GALT7: A Potential Drug Target and Biomarker for Proteostasis

Proteostasis is a critical regulatory process that maintaining the balance of protein synthesis and degradation is essential for various physiological functions. Disruptions in protein homeostasis have been implicated in numerous diseases, including cancer, neurodegenerative disorders, and systemic inflammatory diseases. One of the key protein involved in maintaining protein homeostasis is B4GALT7 (xylosylprotein beta-1,4-galactosyltransferase), which has been identified as a potential drug target and biomarker.

B4GALT7: A Protein involved in Protein Homeostasis

B4GALT7 is a protein that belongs to the B4GALT family, which is known for their role in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway plays a crucial role in the development, maintenance, and regression of tissues, and is involved in a wide range of physiological processes, including cell growth, differentiation, and inflammation.

B4GALT7 is a 21-kDa protein that is expressed in various tissues, including muscle, heart, brain, and organs. It is involved in the transfer of beta-1,4-galactosyl groups from the major basic chain to specific protein targets, which is a critical step in the formation of the disacetylated form of protein. This process is essential for maintaining the stability and integrity of proteins, which are critical for their function and stability.

Disease-Related Implications of B4GALT7

The disruption of B4GALT7 function has been implicated in numerous diseases, including cancer, neurodegenerative disorders, and systemic inflammatory diseases. B4GALT7 is involved in the regulation of several key proteins that are involved in disease development and progression.

In cancer, B4GALT7 has been shown to play a critical role in the regulation of cell cycle progression and the maintenance of stem-like properties of cancer cells. B4GALT7 has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed to support tumor growth.

In neurodegenerative disorders, B4GALT7 has been shown to play a critical role in the regulation of neurotransmitter synthesis and release, which is essential for maintaining the integrity of neural circuits. B4GALT7 has also been shown to be involved in the regulation of cellular stress, which is essential for maintaining the resilience of neural circuits in response to environmental stimuli.

In systemic inflammatory diseases, B4GALT7 has been shown to play a critical role in the regulation of inflammation and immune response. B4GALT7 has also been shown to be involved in the regulation of cytokine production and the regulation of cellular signaling pathways that are involved in inflammation.

Potential Drug Target and Biomarker

The potential drug target of B4GALT7 is the regulation of protein homeostasis, which is critical for maintaining the balance of protein synthesis and degradation. Disruptions in protein homeostasis have been implicated in numerous diseases, including cancer, neurodegenerative disorders, and systemic inflammatory diseases.

B4GALT7 has been shown to be involved in the regulation of several key proteins that are involved in protein homeostasis. Therefore, it may be a potential drug target for diseases that are characterized by disruptions in protein homeostasis.

In addition to its potential drug target potential, B4GALT7 has also been identified as a potential biomarker for several diseases. The regulation of protein homeostasis is essential for maintaining the balance of protein synthesis and degradation, which is critical for the development and maintenance of tissues. Therefore, changes in the regulation of protein homeostasis can

Protein Name: Beta-1,4-galactosyltransferase 7

Functions: Required for the biosynthesis of the tetrasaccharide linkage region of proteoglycans, especially for small proteoglycans in skin fibroblasts

The "B4GALT7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about B4GALT7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets